Target intelligence / Profile preview

Glycine (Gly)

Target: Gly
Molecular classification: Amino acid, Neurotransmitter

Overview

Glycine is the simplest stable amino acid, essential for protein structure and acting as an inhibitory neurotransmitter in the central nervous system. It participates in synthesizing creatine, purine nucleotides, and is a major component of collagen.

Other names: Aminoacetic acidGlycol

Mechanism of action

Inhibitory neurotransmission (via glycine receptors); Precursor to various biomolecules

Biological functions

Protein synthesisNeurotransmissionMetabolic precursorCollagen synthesis

Disease associations

Neurological disordersConnective tissue disordersMetabolic disordersCardiovascular diseaseStroke

Safety considerations

Excessive intake may disrupt amino acid balancePotential interactions with medicationsOveruse as additive, especially in children

Beyond the preview

Go deeper on Glycine (Gly).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycine (Gly).

Explore the full profile